Anti-Human AGPAT2 Polyclonal Antibody

This gene encodes a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in this gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
List Price: $398
  • Buy 5 for $378.1 each and save 5%
  • Buy 21 for $358.2 each and save 10%
  • Buy 31 for $338.3 each and save 15%
  • Buy 51 for

Properties

Data Sheet Click for Datasheet
Catalog Number PA08432
Size 100μl
Host Type Rabbit
Immunogen Synthetic peptide of human AGPAT2
Specificity Expressed predominantly in heart and liver.
Isotype IgG
Reacitivity Human
Clone
Uniprot O15120
Concentration 0.2 mg/mL
Dilution WB 1:500-1:2000
Formulation
Application WB,ELISA
Other Names 1 acyl sn glycerol 3 phosphate acyltransferase beta,1 acylglycerol 3 phosphate O acyltransferase 2,1 AGP acyltransferase 2,1 AGPAT2,1-acyl-sn-glycerol-3-phosphate acyltransferase beta,1-acylglycerol-3-phosphate O-acyltransferase 2,1-AGP acyltransferase 2,1-AGPAT 2,Agpat2,Berardinelli Seip congenital lipodystrophy,BSCL,BSCL1,EC 2.3.1.51,LPAAB,LPAAT beta,LPAAT-beta,Lysophosphatidic acid acyltransferase beta,PLCB
Storage Lyophilized product: 5 years at 2 - 8°C; Solution: 2 years at -20°C.
Postscript For research use only, not for use in diagnostic procedures.

© Copyright 2024 TZYBIOTECH. All Rights Reserved. SiteMap